Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Collplant Holdings (CLGN)
NASDAQ:CLGN
RESEARCH TOOLSreports
Holding CLGN?
Track your performance easily
CLGN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.31 - $6.99
Previous Close$3.41
Volume16.60K
Average Volume (3M)13.37K
Market Cap
$39.06M
Enterprise Value$15.30M
Total Cash (Recent Filing)$26.91M
Total Debt (Recent Filing)$3.16M
Price to Earnings (P/E)―
Beta0.64
Next Earnings
Apr 02, 2025EPS Estimate
-$0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.52
Shares Outstanding11,452,672
10 Day Avg. Volume18,804
30 Day Avg. Volume13,374
Standard Deviation0.19
R-Squared0.01
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)1.38
Price to Sales (P/S)3.56
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue87.45
Enterprise Value/Gross Profit1.71
Enterprise Value/Ebitda-1.89
Forecast
1Y Price Target
$11.00Price Target Upside222.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Collplant Holdings News
PremiumCompany Announcements
CollPlant Biotechnologies’ Q3 2024 Financial Update
PremiumCompany Announcements
CollPlant Biotechnologies Eyes Market with Innovative Implants
PremiumCompany Announcements
CollPlant Shareholders Approve Key Proposals
PremiumCompany Announcements
CollPlant Announces Upcoming Shareholder Meeting
PremiumCompany Announcements
CollPlant Pursues $3B Market with 3D-Printed ImplantsOwnership Overview
―
Insiders
0.05% Mutual Funds
11.81% Other Institutional Investors
88.14% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CLGN FAQ
What was Collplant Holdings’s price range in the past 12 months?
Collplant Holdings lowest stock price was $3.31 and its highest was $6.99 in the past 12 months.
What is Collplant Holdings’s market cap?
Currently, no data Available
When is Collplant Holdings’s upcoming earnings report date?
Collplant Holdings’s upcoming earnings report date is Apr 02, 2025 which is in 101 days.
How were Collplant Holdings’s earnings last quarter?
Collplant Holdings released its earnings results on Nov 27, 2024. The company reported -$0.38 earnings per share for the quarter, missing the consensus estimate of -$0.285 by -$0.095.
Is Collplant Holdings overvalued?
According to Wall Street analysts Collplant Holdings’s price is currently Undervalued.
Does Collplant Holdings pay dividends?
Collplant Holdings does not currently pay dividends.
What is Collplant Holdings’s EPS estimate?
Collplant Holdings’s EPS estimate is -$0.13.
How many shares outstanding does Collplant Holdings have?
Collplant Holdings has 11,454,512 shares outstanding.
What happened to Collplant Holdings’s price movement after its last earnings report?
Collplant Holdings reported an EPS of -$0.38 in its last earnings report, missing expectations of -$0.285. Following the earnings report the stock price went down -0.235%.
Which hedge fund is a major shareholder of Collplant Holdings?
Among the largest hedge funds holding Collplant Holdings’s share is ARK Investment Management LLC. It holds Collplant Holdings’s shares valued at N/A.
---
Collplant Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.00 (222.58% Upside)
$11.00 (222.58% Upside)
Hedge Fund Trend
Decreased
By 235.7K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.98%
12-Months-Change
Fundamentals
Return on Equity
-70.65%
Trailing 12-Months
Asset Growth
-40.25%
Trailing 12-Months
Company Description
Collplant Holdings
CollPlant Biotechnologies Ltd. is a regenerative medicine company. It engages in the research, development, manufacture and marketing of medical products for tissue repair, initially for orthobiologics and advanced wound care markets. The company's products include VergenixSTR, VergenixFG, CollPlant Surgical Matrix. Collplant Holdings was founded by in June 2004 and is headquartered in Ness-Ziona, Israel.
---
CLGN Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented significant advancements in the regenerative breast implant program and ongoing collaborations, particularly with AbbVie, indicating strong potential for future growth. However, financial performance showed a substantial decline in revenue and increased net losses, highlighting financial challenges.Read More>---
CLGN Stock 12 Month Forecast
Average Price Target
$11.00
▲(222.58% Upside)
Technical Analysis
Best Analysts Covering CLGN
1 Year
1 Year Success Rate
5/15 ratings generated profit
1 Year Average Return
-1.73%
initiated a buy rating 5 months ago
Copying Jason Kolbert's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -1.73% per trade.
---